Tag Archives: anacetrapib

Drugs that raise HDL confer no extra clinical benefit when added to a statin

coronary artery disease

mdCurrent Conference Report: American College of Cardiology’s 61st Annual Scientific Session & Expo Adding a therapy that boosts the level of high-density lipoprotein (HDL) cholesterol in a patient already taking a statin is unlikely to produce a substantial clinical benefit, according to the results of a meta-regression analysis. Key Point:… 

Read more »
Posted in Cardiology, Cardiovascular Disease, Non-Communicable Disease, Pharmacology, Primary Care | Also tagged , , , , , , , , , , , | Volume: | Leave a comment